INS and type 2 diabetes mellitus: The proportion of subjects in the comparison group who used insulins and insulin analogs without concomitant treatment with T2DM medication, i.e. primarily individuals with T1DM, was 0.67%, a similar proportion to that seen in the population in general in Sweden.28 The proportion of individuals with T1DM treatment in the obese cohort was much lower.